Lista de obras - Karuppiah Muthumani - Dominio Público Uruguay

A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates

artículo científico publicado en 2011

A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.

artículo científico publicado en 2011

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

artículo científico publicado en 2020

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

artículo científico publicado en 2015

Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides.

artículo científico publicado en 2010

Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium.

artículo científico publicado en 2013

Chikungunya: a potentially emerging epidemic?

artículo científico publicado en 2010

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

artículo científico publicado en 2014

Complete Regression of Established Subcutaneous B16 Murine Melanoma Tumors after Delivery of an HIV-1 Vpr-Expressing Plasmid by in Vivo Electroporation

article

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses

scientific article published in 2022

DNA vaccines for targeting bacterial infections.

artículo científico publicado en 2010

DR5 Activation of Caspase-8 Induces DC Maturation and Immune Enhancement In Vivo

scientific article published on 18 December 2007

HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo

artículo científico publicado en 2013

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation

artículo científico publicado en 2005

HIV-1 Viral Protein-R (VPR) Protects against Lethal Superantigen Challenge While Maintaining Homeostatic T Cell Levels in Vivo

article

HIV-1 Vpr and anti-inflammatory activity

artículo científico publicado en 2004

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells

artículo científico publicado en 2002

HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro

article

HIV-1 viral genes and mitochondrial apoptosis.

artículo científico publicado en 2008

HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells

artículo científico publicado en 2011

Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism

artículo científico publicado en 2005

Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism

artículo científico publicado en 2008

Immunogenicity of a DNA vaccine candidate for COVID-19

scientific article published on 20 May 2020

Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

artículo científico publicado en 2015

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

artículo científico publicado en 2008

In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia.

artículo científico publicado en 2013

Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway

artículo científico publicado en 2002

Mechanism of HIV-1 viral protein R-induced apoptosis ⬇️

artículo científico publicado el 9 de mayo de 2003

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

artículo científico publicado en 2011

Molecular characterization of Chikungunya virus during an outbreak in South India.

artículo científico publicado en 2010

Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine

artículo científico publicado en 2013

Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.

artículo científico publicado en 2013

Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.

artículo científico publicado en 2009

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy

artículo científico publicado en 2015

Protective immunity by an engineered DNA vaccine for Mayaro virus

artículo científico publicado en 2019

Protocols for Developing Novel Chikungunya Virus DNA Vaccines.

artículo científico publicado en 2016

REDD1 Is Essential for Optimal T Cell Proliferation and Survival

artículo científico publicado en 2015

RETRACTED ARTICLE: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance

artículo científico publicado en 2020

Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection.

artículo científico publicado en 2011

SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

article

Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects

artículo científico publicado en 2015

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

artículo científico publicado en 2013

The HIV-1 Accessory Gene vpr Can Inhibit Antigen-Specific Immune Function

article

The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.

artículo científico publicado en 2008

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

artículo científico publicado en 2006

VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus

article

Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

artículo científico publicado en 2012

Lista de obras de Karuppiah Muthumani

A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates

A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides.

Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium.

Chikungunya: a potentially emerging epidemic?

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

Complete Regression of Established Subcutaneous B16 Murine Melanoma Tumors after Delivery of an HIV-1 Vpr-Expressing Plasmid by in Vivo Electroporation

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses

DNA vaccines for targeting bacterial infections.

DR5 Activation of Caspase-8 Induces DC Maturation and Immune Enhancement In Vivo

HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation

HIV-1 Viral Protein-R (VPR) Protects against Lethal Superantigen Challenge While Maintaining Homeostatic T Cell Levels in Vivo

HIV-1 Vpr and anti-inflammatory activity

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells

HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro

HIV-1 viral genes and mitochondrial apoptosis.

HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells

Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism

Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism

Immunogenicity of a DNA vaccine candidate for COVID-19

Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia.

Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway

Mechanism of HIV-1 viral protein R-induced apoptosis ⬇️

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

Molecular characterization of Chikungunya virus during an outbreak in South India.

Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine

Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.

Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy

Protective immunity by an engineered DNA vaccine for Mayaro virus

Protocols for Developing Novel Chikungunya Virus DNA Vaccines.

REDD1 Is Essential for Optimal T Cell Proliferation and Survival

RETRACTED ARTICLE: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance

Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection.

SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

The HIV-1 Accessory Gene vpr Can Inhibit Antigen-Specific Immune Function

The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus

Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.